Statistical and clinical significance, sensitivity, specificity and cost-benefit analysis in clinical practice.
暂无分享,去创建一个
[1] R. Landewé,et al. The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA , 2020, Annals of the rheumatic diseases.
[2] E. Keystone,et al. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials , 2019, Rheumatology.